Journal of the Korean Society of Physical Medicine (대한물리의학회지)

The Korean Society of Physical Medicine (대한물리의학회)
권호 표지
DOI QR코드

DOI QR Code

Sarcopenic Obesity Frequency and Associated Risk Factors in Young Korean Women: A Comprehensive Cross-Sectional Analysis

  • Received : 2024.01.25
  • Accepted : 2024.02.01
  • Published : 2024.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

PURPOSE: Sarcopenic obesity (SO) is a clinical condition that combines sarcopenia and obesity. This study examined the frequency of SO in young Korean females between 20 and 29 years of age. METHODS: The study involved 1,000 participants. The height, weight, body mass index (BMI), waist circumference, skeletal muscle mass index, fasting glucose, triglyceride, total cholesterol levels, systolic and diastolic blood pressure, alcohol consumption, and smoking status were the research variables. The skeletal muscle mass index was calculated as appendicular skeletal muscle mass (ASM) divided by the BMI. The ASM was assessed using dual X-ray absorptiometry. Complex sampling analysis and multiple logistic regression were used for analysis. RESULTS: A .74(.30-1.80) frequency of SO was observed. The statistically significant risk factors in females were height, weight, BMI, waist circumference, skeletal muscle mass index, total cholesterol, systolic blood pressure, and diastolic blood pressure (p < .05). CONCLUSION: Young Korean adults with SO have a .74(.30-1.80) frequency of occurrence that is linked to specific risk factors. Hence, primary care clinicians and health care professionals should consider these factors when patients require a referral for early detection and treatment. Healthcare professionals and clinicians can identify potential SO patients by acknowledging these risk factors.

Keywords

References

  1. Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obesity Facts. 2022;15(3):321-35.  https://doi.org/10.1159/000521241
  2. Donini LM, Busetto L, Bauer JM, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020;39(8):2368-88.  https://doi.org/10.1016/j.clnu.2019.11.024
  3. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res. 2004;12(6):887-8.  https://doi.org/10.1038/oby.2004.107
  4. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-60.  https://doi.org/10.1111/jgs.12652
  5. Kulik CT, Ryan S, Harper S, et al. Aging populations and management. Academy of Management Briarcliff Manor, NY. 2014. pp.929-35. 
  6. Yang YS, Han BD, Han K, et al. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022;31(2):169-77.  https://doi.org/10.7570/jomes22024
  7. Reijnierse EM, de van der Schueren MAE, Trappenburg MC, et al. Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management. PLoS One. 2017;12(10):e0185837. 
  8. Mehiret G, Molla A, Tesfaw A. Knowledge on risk factors and practice of early detection methods of breast cancer among graduating students of Debre Tabor University, Northcentral Ethiopia. BMC Womens Health. 2022;22(1):183. 
  9. Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51(11):1602-9.  https://doi.org/10.1046/j.1532-5415.2003.51534.x
  10. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693. 
  11. Hirani V, Naganathan V, Blyth F, et al. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. Age and Ageing. 2017;46(3):413-20. https://doi.org/10.1093/ageing/afw214
  12. Sanada K, Chen R, Willcox B, et al. Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: the Kuakini Honolulu heart program. Nutrition. 2018;46:97-102.  https://doi.org/10.1016/j.nut.2017.09.003
  13. Hwang J, Park S. Sex differences of sarcopenia in an elderly Asian population: the prevalence and risk factors. Int J Environ Res Public Health. 2022;19(19): 11980. 
  14. Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-dwelling young-old adults. Int J Environ Res Public Health. 2022;19(12):7232. 
  15. Hwang J. Coexistence of age-related loss of skeletal muscle mass and obesity in korean men in their thirties: understanding incidence rate and key influencing elements. J Korean Soc Phys Med. 2023;18(4):37-45.  https://doi.org/10.13066/kspm.2023.18.4.37
  16. Hwang J. Analyzing proportion and susceptibility markers of sarcopenia in Korean younger female. J Korean Soc Phys Med. 2023;18(4):19-27. 
  17. Hwang J. Unraveling the contributing factors of sarcopenia in young Korean male adults: a study of occurrence, somatometric, biochemical, and behavioral characteristics. J Korean Soc Phys Med. 2023;18(3): 21-30.  https://doi.org/10.13066/kspm.2023.18.3.21
  18. Hwang J. Comprehensive investigation on the prevalence and risk factors of coexistence of age-related loss of skeletal muscle mass and obesity among males in their 40s. J Korean Soc Phys Med. 2023;18(3):1-9.  https://doi.org/10.13066/kspm.2023.18.3.1
  19. Hwang J. Age-related loss of skeletal muscle and associated risk factors in middle-aged men: a comprehensive study. J Korean Soc Phys Med. 2023;18(2):13-21. 
  20. Hwang J. Prevalence, anthropometric risk factors, and clinical risk factors in sarcopenic women in their 40s. J Korean Soc Phys Med. 2023;18(2):23-31.  https://doi.org/10.3346/jkms.2003.18.1.23
  21. Hwang J, Moon IY. Exploring incidence and potential risk factors of sarcopenic obesity among middle-aged women residing in a community. J Korean Soc Phys Med. 2023;18(3):11-9.  https://doi.org/10.13066/kspm.2023.18.3.11
  22. Hwang J, Park S. A Korean nationwide cross-sectional study investigating risk factors, prevalence, and characteristics of sarcopenia in men in early old age. Healthcare. MDPI. 2023. pp.2860. 
  23. Hwang J, Park S. Gender-specific prevalence and risk factors of sarcopenic obesity in the korean elderly population: a nationwide cross-sectional study. Int J Environ Res Public Health. 2023;20(2):1140. 
  24. Lexell J, Downham D, Sjostrom M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of healthy men between 15 and 83 years. J Neurol Sci. 1986;72(2-3):211-22.  https://doi.org/10.1016/0022-510X(86)90009-2
  25. Kehayias JJ, Fiatarone MA, Zhuang H, et al. Total body potassium and body fat: relevance to aging. Am J Clin Nutr. 1997;66(4):904-10. 
  26. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8.  https://doi.org/10.1152/jappl.2000.89.1.81
  27. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96.  https://doi.org/10.1046/j.1532-5415.2002.50216.x
  28. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.  https://doi.org/10.1093/ageing/afy169
  29. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. In: National Center for Health S, National Health Statistics Reports. Hyattsville, MD. http://dx.doi.org/10.15620/cdc:106273. 2021. 
  30. Hwang J, Kim N-h. Comprehensive cross-sectional study of sarcopenia in young Korean women: assessing body dimensions, clinical indicators, and behavioral traits for hazardous components and proportional analysis. J Korean Soc Phys Med. 2023. 
  31. Hwang J, Lee J. Factors influencing age-related loss of skeletal muscle mass in young Korean men. J Korean Soc Phys Med. 2023;18(4):67-75.  https://doi.org/10.13066/kspm.2023.18.4.67
  32. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-58.  https://doi.org/10.1093/gerona/glu010
  33. Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-7.  https://doi.org/10.1016/j.orcp.2012.02.003
  34. Perna S, Peroni G, Faliva MA, et al. Sarcopenia and sarcopenic obesity in comparison: prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly. Aging Clin Exp Res. 2017;29(6):1249-58.  https://doi.org/10.1007/s40520-016-0701-8
  35. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109. 
  36. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81.  https://doi.org/10.1530/JOE-15-0533
  37. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25.  https://doi.org/10.1152/japplphysiol.00627.2006
  38. Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38-50.  https://doi.org/10.1016/j.cytogfr.2018.10.002
  39. Yin T, Zhang JX, Wang FX, et al. The association between sarcopenic obesity and hypertension, diabetes, and abnormal lipid metabolism in chinese adults. Diabetes Metab Syndr Obes. 2021;14:1963-73.  https://doi.org/10.2147/DMSO.S308387
  40. Ferreira I, Snijder MB, Twisk JW, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? the amsterdam growth and health longitudinal study. J Clin Endocrinol Metab. 2004;89(6):2632-9.  https://doi.org/10.1210/jc.2003-031619
  41. Snijder MB, Henry RM, Visser M, et al. Regional body composition as a determinant of arterial stiffness in the elderly: the hoorn study. J Hypertens. 2004;22(12):2339-47.  https://doi.org/10.1097/00004872-200412000-00016
  42. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183-9.  https://doi.org/10.1111/j.1559-4564.2007.06673.x
  43. Goswami B, Reang T, Sarkar S, et al. Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura-A comparative study. J Family Med Prim Care. 2020;9(6):2885-90.  https://doi.org/10.4103/jfmpc.jfmpc_187_20